Intervention

Cognitive assessments

ClinicalTrials.gov intervention label

Clinical trials4

Recruiting1

Common conditions7

Lead sponsors shown3

Clinical trials

4 shown

Study to Understand Novel Biomarkers in Researching DementiaNCT06547099 · 2024-08-14

Predicting Cognitive Decline From Androgen Deprivation TherapyNCT05820932 · 2023-05-22

Establish Diagnostic Models Based on Olfactory Function and Odor-induced Brain Activation for Diabetes-Related Cognitive ImpairmentNCT05543967 · 2022-10-18

Relationship and Central Mechanism Between Diabetes and Cognitive Impairment Based on Simultaneous EEG-fMRI Approach and Peripheral Neuropathology Biomarkers AssayNCT05545657 · 2022-10-18

Common conditions

Alzheimer Disease2 Cognitive Impairment2 Dementia1 Mild Cognitive Impairment1 Prostate Cancer1 Type 2 Diabetes1 Type 2 Diabetes Mellitus1

Leading sponsors

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School2 University of California, San Francisco1 Washington University School of Medicine1

Trial status mix

UNKNOWN2

RECRUITING1

TERMINATED1

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.